Clinical Trial Update: Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a single intravitreal injection of Triamcinolone acetonide to Bevacizumab for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Universidade Federal de Goias | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED